132 related articles for article (PubMed ID: 21553120)
1. Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs.
Guttilla IK; Phoenix KN; Hong X; Tirnauer JS; Claffey KP; White BA
Breast Cancer Res Treat; 2012 Feb; 132(1):75-85. PubMed ID: 21553120
[TBL] [Abstract][Full Text] [Related]
2. Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.
Zhang W; Qian P; Zhang X; Zhang M; Wang H; Wu M; Kong X; Tan S; Ding K; Perry JK; Wu Z; Cao Y; Lobie PE; Zhu T
J Biol Chem; 2015 May; 290(22):13812-29. PubMed ID: 25873390
[TBL] [Abstract][Full Text] [Related]
3. Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axis.
Avtanski DB; Nagalingam A; Tomaszewski JE; Risbood P; Difillippantonio MJ; Saxena NK; Malhotra SV; Sharma D
Mol Oncol; 2016 Aug; 10(7):1118-32. PubMed ID: 27259808
[TBL] [Abstract][Full Text] [Related]
4. Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancer.
Miano V; Ferrero G; Reineri S; Caizzi L; Annaratone L; Ricci L; Cutrupi S; Castellano I; Cordero F; De Bortoli M
Oncotarget; 2016 Jan; 7(3):3201-16. PubMed ID: 26621851
[TBL] [Abstract][Full Text] [Related]
5. Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells.
Gauck D; Keil S; Niggemann B; Zänker KS; Dittmar T
BMC Cancer; 2017 Aug; 17(1):515. PubMed ID: 28768501
[TBL] [Abstract][Full Text] [Related]
6. Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial-Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer.
Nair MG; Mavatkar AD; Naidu CM; V P S; C E A; Rajarajan S; Sahoo S; Mohan G; Jaikumar VS; Ramesh RS; B S S; Jolly MK; Maliekal TT; Prabhu JS
Cells; 2024 May; 13(10):. PubMed ID: 38786043
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC).
Graham ÉA; Mallet JF; Jambi M; Nishioka H; Homma K; Matar C
Cancer Biol Ther; 2017 Oct; 18(10):765-774. PubMed ID: 28886271
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-200 family modulation in distinct breast cancer phenotypes.
Castilla MÁ; Díaz-Martín J; Sarrió D; Romero-Pérez L; López-García MÁ; Vieites B; Biscuola M; Ramiro-Fuentes S; Isacke CM; Palacios J
PLoS One; 2012; 7(10):e47709. PubMed ID: 23112837
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem-like cells with hybrid epithelial/mesenchymal phenotype leading the collective invasion.
Quan Q; Wang X; Lu C; Ma W; Wang Y; Xia G; Wang C; Yang G
Cancer Sci; 2020 Feb; 111(2):467-476. PubMed ID: 31845453
[TBL] [Abstract][Full Text] [Related]
10. Mammospheres of letrozole-resistant breast cancer cells enhance breast cancer aggressiveness.
Patel JR; Gallegos KM; Walker RR; Davidson AM; Davenport I; Tilghman SL
Oncol Lett; 2021 Aug; 22(2):620. PubMed ID: 34267813
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells.
Al Saleh S; Al Mulla F; Luqmani YA
PLoS One; 2011; 6(6):e20610. PubMed ID: 21713035
[TBL] [Abstract][Full Text] [Related]
12. PyMT-1099, a versatile murine cell model for EMT in breast cancer.
Saxena M; Kalathur RKR; Neutzner M; Christofori G
Sci Rep; 2018 Aug; 8(1):12123. PubMed ID: 30108334
[TBL] [Abstract][Full Text] [Related]
13. Aminoflavone upregulates putative tumor suppressor miR-125b-2-3p to inhibit luminal A breast cancer stem cell-like properties.
Mavingire N; Campbell P; Liu T; Wooten J; Khan S; Chen X; Matthews J; Wang C; Brantley E
Precis Clin Med; 2022 Jun; 5(2):pbac008. PubMed ID: 35694715
[TBL] [Abstract][Full Text] [Related]
14. Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts.
Tisza MJ; Zhao W; Fuentes JS; Prijic S; Chen X; Levental I; Chang JT
Oncotarget; 2016 Aug; 7(32):51553-51568. PubMed ID: 27303921
[TBL] [Abstract][Full Text] [Related]
15. The TGFβ2-Snail1-miRNA
Luo L; Xu N; Fan W; Wu Y; Chen P; Li Z; He Z; Liu H; Lin Y; Zheng G
Clin Transl Med; 2024 Feb; 14(2):e1558. PubMed ID: 38299307
[TBL] [Abstract][Full Text] [Related]
16. Delivery of Protein Kinase A by CRISPRMAX and Its Effects on Breast Cancer Stem-Like Properties.
Zhou JN; Rautio TC; Liu C; Xu XY; Wang DQ; Guo Y; Eriksson J; Zhang H
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374889
[TBL] [Abstract][Full Text] [Related]
17. Characterization of MCF-12A cell phenotype, response to estrogens, and growth in 3D.
Sweeney MF; Sonnenschein C; Soto AM
Cancer Cell Int; 2018; 18():43. PubMed ID: 29559854
[TBL] [Abstract][Full Text] [Related]
18. The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer.
Weigelt B; Ghajar CM; Bissell MJ
Adv Drug Deliv Rev; 2014 Apr; 69-70():42-51. PubMed ID: 24412474
[TBL] [Abstract][Full Text] [Related]
19. A detailed mammosphere assay protocol for the quantification of breast stem cell activity.
Shaw FL; Harrison H; Spence K; Ablett MP; Simões BM; Farnie G; Clarke RB
J Mammary Gland Biol Neoplasia; 2012 Jun; 17(2):111-7. PubMed ID: 22665270
[TBL] [Abstract][Full Text] [Related]
20. Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin.
Manuel Iglesias J; Beloqui I; Garcia-Garcia F; Leis O; Vazquez-Martin A; Eguiara A; Cufi S; Pavon A; Menendez JA; Dopazo J; Martin AG
PLoS One; 2013; 8(10):e77281. PubMed ID: 24124614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
